Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. News
  7. Summary
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Amgen : Mizuho Securities Lifts Amgen's Price Target to $222 From $200, Citing Lumakras Sales Estimates, Pipeline Products; Neutral Rating Kept

08/12/2021 | 05:53am EDT


ę MT Newswires 2021
All news about AMGEN INC.
04:01pFortune and Great Place to Work« Name Amgen One of the World's Best Workplaces™ i..
PR
10/25ANALYSIS : Capitol Hill drug pricing reform opponents among the biggest beneficiaries of p..
RE
10/21AMGEN : Keeps Quarterly Dividend at $1.76 a Share, Payable Dec. 8 to Stockholders of Recor..
MT
10/21AMGEN : Announces 2021 Fourth Quarter Dividend
PR
10/21Amgen Inc. Declares Dividend for the Fourth Quarter of 2021, Payable on December 8, 202..
CI
10/21AMGEN : Introducing Undruggable, a New Serial Podcast from Amgen R&D Exploring how Multisp..
PU
10/20AMGEN : A Special Edition of Innovation2, brought to you by David and Jim Reese (Brothers2..
PU
10/20CARLYLE : Venture Funds Invest Up to $430 Million in Saama Technologies
MT
10/19AMGEN : Completes Teneobio Acquisition
MT
10/19AMGEN : Successfully Completes Acquisition Of Teneobio, Inc.
PR
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Financials (USD)
Sales 2021 26 010 M - -
Net income 2021 5 801 M - -
Net Debt 2021 22 276 M - -
P/E ratio 2021 20,7x
Yield 2021 3,37%
Capitalization 118 B 118 B -
EV / Sales 2021 5,41x
EV / Sales 2022 5,08x
Nbr of Employees 24 300
Free-Float 99,8%
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | AMGN | US0311621009 | MarketScreener
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 208,68 $
Average target price 243,14 $
Spread / Average Target 16,5%
EPS Revisions
Managers and Directors
Robert A. Bradway Chairman, President & Chief Executive Officer
Peter H. Griffith Chief Financial Officer & Executive Vice President
David M. Reese Executive Vice President-Research & Development
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Mike Zahigian Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
AMGEN INC.-9.24%117 903
JOHNSON & JOHNSON4.26%431 938
ROCHE HOLDING AG15.61%338 364
NOVO NORDISK A/S59.69%243 351
PFIZER, INC.17.25%241 929
ELI LILLY AND COMPANY45.14%222 158